It is feasible to upgrade to a dual-chamber leadless pacemaker using a hybrid system from two different manufacturers.
This case demonstrates the feasibility of achieving a hybrid dual-chamber leadless pacing system from two different manufacturers in selected patients.
Cravo et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: